Catrina Uhlmann

786 total citations
3 papers, 90 citations indexed

About

Catrina Uhlmann is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Catrina Uhlmann has authored 3 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Cancer Research and 1 paper in Genetics. Recurrent topics in Catrina Uhlmann's work include HER2/EGFR in Cancer Research (1 paper), MRI in cancer diagnosis (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Catrina Uhlmann is often cited by papers focused on HER2/EGFR in Cancer Research (1 paper), MRI in cancer diagnosis (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Catrina Uhlmann collaborates with scholars based in Switzerland and Chile. Catrina Uhlmann's co-authors include Matthias Bruehlmeier, Martin Hefti, Silvia Höfer, U.W. Buettner, Ulrich Roelcke, Matthias T. Wyss, Stefan Aebi, Walter Mingrone, Christoph Rochlitz and Peter Brauchli and has published in prestigious journals such as Journal of Neuro-Oncology, Oncology and Onkologie.

In The Last Decade

Catrina Uhlmann

3 papers receiving 89 citations

Peers

Catrina Uhlmann
Ann Holmes United Kingdom
Kristen Curtis United States
Hussain AlHussain Saudi Arabia
Renunda Hicks United Kingdom
Marco Matos Australia
R. Andrew Harkins United States
Kendrick Tang United States
Susie Brain United States
Ann Holmes United Kingdom
Catrina Uhlmann
Citations per year, relative to Catrina Uhlmann Catrina Uhlmann (= 1×) peers Ann Holmes

Countries citing papers authored by Catrina Uhlmann

Since Specialization
Citations

This map shows the geographic impact of Catrina Uhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catrina Uhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catrina Uhlmann more than expected).

Fields of papers citing papers by Catrina Uhlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catrina Uhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catrina Uhlmann. The network helps show where Catrina Uhlmann may publish in the future.

Co-authorship network of co-authors of Catrina Uhlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Catrina Uhlmann. A scholar is included among the top collaborators of Catrina Uhlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catrina Uhlmann. Catrina Uhlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Moos, Roger von, Arnaud Roth, Thomas Ruhstaller, et al.. (2010). Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03). Onkologie. 33(6). 295–299. 3 indexed citations
2.
Wyss, Matthias T., Silvia Höfer, Matthias Bruehlmeier, et al.. (2009). Early metabolic responses in temozolomide treated low-grade glioma patients. Journal of Neuro-Oncology. 95(1). 87–93. 72 indexed citations
3.
Uhlmann, Catrina, Pierluigi Ballabeni, Peter Brauchli, et al.. (2004). Capecitabine with Weekly Paclitaxel for Advanced Breast Cancer: A Phase I Dose-Finding Trial. Oncology. 67(2). 117–122. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026